In addition, MEX3A and TTYH3 correlated with shorter overall survival of patients with HPV-negative cervical cancer, suggesting that the upregulation of MEX3A and TTYH3 were not only associated with the development of HPV-negative cervical cancer but also specifically involved in the prognosis of HPV-negative cervical cancer. Here, TTYH3 is linked to cervical cancer.